BOSTON – Jan.12, 2024 – David J. Dykeman and Andrew (A.J.) Tibbetts, shareholders in global law firm Greenberg Traurig, LLP’s Boston office presented a MassMEDIC webinar, titled “Trends in MedTech for 2024,” on Jan. 11 at noon EST. The event took place live from San Francisco during the JP Morgan Healthcare Conference.
Dykeman and Tibbetts were joined by medtech experts Ed McNamara, senior vice president of life sciences and medtech at Bridge Bank, and Bhavesh Barot, operating partner at Truffle Capital. The presenters discussed trends in financing, mergers and acquisitions, intellectual property, and the transformative role of artificial intelligence (AI) in shaping the future of healthcare.
Dykeman is co-chair of Greenberg Traurig’s global Life Sciences & Medical Technology Group and co-managing shareholder of the Boston office. He focuses on securing worldwide intellectual property protection and related business strategies for high-tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology. He provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multinational corporations, and start-up companies. He serves on the board of directors of MassMEDIC and previously served on the editorial advisory board for Medical Device & Diagnostic Industry (MD+DI) Magazine.
Tibbetts, an Intellectual Property & Technology shareholder in the firm’s Boston office, leverages his prior experience as a software engineer to provide practical intellectual property strategy counseling on matters related to software-implemented tech across a range of industries, from networking, fintech, and natural language processing through to life sciences, artificial intelligence, medical records, and medical devices. He advises a wide array of clients on intellectual property strategies, ranging from international and publicly traded companies and large research institutions to small and growing companies. He serves on the board of directors of MassMEDIC and HealthTech Build, helping to support digital health efforts in the New England area.
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig’s Intellectual Property & Technology Practice: With more than 260 intellectual property attorneys and patent agents in the United States, Asia, and Europe, Greenberg Traurig provides a broad range of patent, trademark and copyright protection and strategic counseling. Greenberg Traurig was named a “National Tier 1” Law Firm for IP Litigation, Patent Law and Litigation, Copyright Law, Technology Law, and Information Technology Law by U.S. News and Best Lawyers, 2023 “Best Law Firms.” In addition, Greenberg Traurig was named a “Law Firm of the Year” for Trademark Law in the 2020 and 2022 editions of “Best Law Firms.” The BTI Consulting Group named Greenberg Traurig’s IP Litigation Practice a ‘Litigation Standout’ in the “BTI Litigation Outlook 2023: Litigation Spending in the Uncertain Economy and Beyond.”
About Greenberg Traurig: Greenberg Traurig, LLP has more than 2650 attorneys in 47 locations in the United States, Europe and the Middle East, Latin America, and Asia. The firm is a 2022 BTI “Highly Recommended Law Firm” for superior client service and is consistently among the top firms on the Am Law Global 100 and NLJ 500. Greenberg Traurig is Mansfield Rule 6.0 Certified Plus by The Diversity Lab. The firm is recognized for powering its U.S. offices with 100% renewable energy as certified by the Center for Resource Solutions Green-e® Energy program and is a member of the U.S. EPA’s Green Power Partnership Program. The firm is known for its philanthropic giving, innovation, diversity, and pro bono. Web: www.gtlaw.com.